By Dr. Chinta Sidharthan Reviewed by Danielle Ellis, B.Sc. Nov 21 2024 Researchers identify gliocidin, a blood-brain barrier-penetrating prodrug, that targets glioblastoma's unique metabolic vulnerability, offering a promising therapeutic strategy and extended survival in preclinical models. Study: Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma . Image Credit: April stock/Shutterstock.com In a recent study published in Nature , a team led by researchers from Memorial